Disagree
Home Beligas Pharmaceuticals Beligas Pharmaceuticals
5-Amino 1MQ 50
5-Amino 1MQ 50 - Beligas Pharmaceuticals

5-Amino 1MQ 50 - Beligas Pharmaceuticals

Brand:
Category:
Substance:
Dosage:
50 mg/tab
Package:
100 tablets
Price:
$195.00 - $195.00
See options
Product Overview

5-Amino-1MQ targets the nicotinamide N-methyltransferase (NNMT) enzyme, which plays a role in metabolic regulation and fat storage. Studies show that it effectively reduces body weight and adipose tissue mass in high-fat diet-induced obese mice. Additionally, it improves cellular energy metabolism by enhancing NAD+ levels and modulating pathways critical to adipocyte differentiation. With its selective and membrane-permeable properties, 5-Amino-1MQ not only reduces obesity-related complications but also supports metabolic health, making it a potential therapeutic option for obesity treatment.

References:

Neelakantan, H., Vance, V., Wetzel, M.D., Wang, H.Y.L., McHardy, S.F., Finnerty, C.C., Hommel, J.D., and Watowich, S.J., 2018. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high-fat diet-induced obesity in mice. Biochemical Pharmacology.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about 5-Amino 1MQ 50 by Beligas Pharmaceuticals, consult with your doctor or healthcare professional.

Products
Show more
Explore More Products
FAQ
What are the main benefits of 5-Amino-1MQ?
The compound reduces adipocyte size, decreases fat mass, enhances lipid metabolism, and supports healthier energy balance, offering potential treatment for obesity.
References:

Neelakantan, H., Vance, V., Wetzel, M.D., Wang, H.Y.L., McHardy, S.F., Finnerty, C.C., Hommel, J.D., and Watowich, S.J., 2018. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high-fat diet-induced obesity in mice. Biochemical Pharmacology.

Has 5-Amino-1MQ been tested for obesity treatment?
Yes, preclinical studies in diet-induced obese mice showed significant reductions in body weight, fat accumulation, and improved metabolic profiles.
References:

Neelakantan, H., Vance, V., Wetzel, M.D., Wang, H.Y.L., McHardy, S.F., Finnerty, C.C., Hommel, J.D., and Watowich, S.J., 2018. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high-fat diet-induced obesity in mice. Biochemical Pharmacology.

How is 5-Amino-1MQ administered?
In preclinical studies, 5-Amino-1MQ was delivered via subcutaneous injections. Its exact administration method for human use is under investigation.
References:

Neelakantan, H., Vance, V., Wetzel, M.D., Wang, H.Y.L., McHardy, S.F., Finnerty, C.C., Hommel, J.D., and Watowich, S.J., 2018. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high-fat diet-induced obesity in mice. Biochemical Pharmacology.